Cleveland Clinic
Research into low-intensity shockwave therapy for vascular ED has produced promising results around blood flow.
Read source ↗
OGO PRIMEARC III · FLAGSHIP
01 / INTERACTIVE PRODUCT STUDY
Scroll through five schematic views. The sequence demonstrates camera, interaction and product-zone storytelling—not verified geometry, internals or construction.
Use this view to understand the intended visual hierarchy only.
The interaction points toward adjustable fit without asserting final dimensions.
Separated zones are editorial storytelling, not an internal diagram.
The connected experience remains in development.
Exact product geometry requires supplier-approved assets or a verified physical sample.
3D preview unavailable
SUPPLIED 3D PRODUCT MODEL · EXTERIOR VISUALIZATION
3D loads when this chapter approaches
PRIMEARC III · PRODUCT VIEW
Explore the 3D model below, or use AR (augmented reality) to place PrimeArc III in your space.
GUIDED PRODUCT TOUR
Clinical context, treatment standards, and consumer-protection principles summarized from independent medical and U.S. consumer sources.
Research into low-intensity shockwave therapy for vascular ED has produced promising results around blood flow.
Read source ↗European guidelines give low-intensity shockwave treatment a weak recommendation for selected men with mild vasculogenic ED and certain PDE5-inhibitor poor responders.
Read source ↗The AUA classifies low-intensity ESWT for ED as investigational.
Read source ↗A review of 21 randomized trials found LiSWT may slightly improve erectile function.
Read source ↗Twelve randomized trials involving 882 men found statistically significant improvements in IIEF-EF and erection-hardness outcomes with Li-ESWT versus sham therapy.
Read source ↗An umbrella review of five systematic reviews found improvements in erectile-function scores; four of five also reported improved erection hardness.
Read source ↗The Sexual Medicine Society of North America notes that early restorative-therapy trials have shown some improvements, particularly in milder ED.
Read source ↗Shockwave therapy is described as a non-invasive approach using targeted sound waves, with blood flow and vascular function central to the research.
Read source ↗ED care can include oral medicines, injections or suppositories, vacuum devices, and surgery—reflecting that treatment pathways vary by the person and clinical situation.
Read source ↗Treatment selection depends on the cause and severity of ED, underlying health conditions, and patient preferences—personalization is part of standard care.
Read source ↗Extended protection has value when it adds meaningful coverage beyond the original warranty.
Read source ↗The prostate sits inside the pelvis. PrimeArc III is designed to meet the body externally at the perineal and scrotal regions—without internal insertion.
The prostate sits within the male pelvis, beneath the bladder. It is shown here as an anatomical reference to illustrate the surrounding structures. PrimeArc is engineered to transmit calibrated micro-acoustic energy through the external skin into the underlying tissue to maintain vascular responsiveness.
The perineum is the external area between the scrotum and anus. PrimeArc's lower contour is designed to align with this region and deliver targeted low-intensity acoustic pressure directly to the underlying perineal tissue.
The scrotal skin contains a dense network of sensory nerves and micro-vessels. PrimeArc's raised silicone nodes are designed to deliver localized micro-acoustic stimulation across this external surface, engaging neurovascular receptors within the skin and underlying tissues.
PrimeArc is shaped to engage both the perineal and scrotal regions within a single external wearable structure. Its geometry positions each contact zone to deliver dual-point micro-acoustic therapy, combining targeted perineal contact with scrotal micro-wave delivery in one integrated at-home system.
Erection is not one event. Neural input, nitric-oxide signaling, smooth-muscle relaxation, blood inflow and reduced venous outflow work together.
Penile afferent input can participate in reflexogenic erection, alongside brain-driven sexual stimuli.
Neural and endothelial nitric oxide contributes to cavernosal smooth-muscle relaxation.
Relaxed smooth muscle allows greater arterial inflow and expansion of erectile tissue.
Expansion compresses venous outflow, helping pressure and firmness rise and remain.
RESEARCH NOTE
These mechanism reviews support the physiology shown here.
Aging does not automatically cause erectile dysfunction, but vascular and tissue changes can make erectile response less efficient for some men.
With age, blood vessels can become less responsive, making it harder to dilate quickly when blood flow needs to increase.
2025 vascular-aging review ↗
Arteries commonly become stiffer with age, which can make rapid increases in blood inflow harder to achieve.
Review the vascular evidence ↗
Age-related tissue change can affect the smooth-muscle and veno-occlusive environment involved in maintaining firmness.
Read the review ↗Genital sensory input is part of sexual-response circuitry. Penile vibratory stimulation has clinical and regulatory precedent.
Viberect is a Class II penile vibratory stimulation device cleared through the FDA 510(k) pathway (K142304), establishing regulatory precedent for therapeutic genital vibration.
FDA 510(k) · K142304 ↗In a five-participant feasibility study of a penile vibratory device, four participants reached greater than 60% rigidity.
View feasibility study ↗In 68 men following nerve-sparing prostatectomy, penile vibratory stimulation was evaluated as part of erectile-function recovery. Erectile-function scores numerically favored the PVS group at 12 months.
View randomized trial ↗PrimeArc III features two calibrated Micro-Acoustic Transducers designed to emit targeted, low-intensity acoustic pressure pulses. This dual-source delivery ensures uniform acoustic energy distribution across the perineal and scrotal target areas for safe, unassisted home application.
One actuator sits beneath the raised silicone texture. A second actuator sits inside the lower handle.
The upper acoustic transducer is positioned horizontally beneath the raised silicone surface, concentrating calibrated micro-acoustic energy directly at the scrotal zone to maintain local vascular responsiveness.
The lower acoustic transducer is aligned vertically within the handle structure, delivering a second independent stream of targeted acoustic pressure directly to the perineal tissue.
PrimeArc III delivers calibrated micro-acoustic energy simultaneously across the scrotal and perineal zones, providing comprehensive dual-point support to complement clinical Li-ESWT.
RESEARCH NOTE · REPEATED HOME STIMULATION
A 2026 pilot investigated daily penile vibratory stimulation as an at-home rehabilitation approach after nerve-sparing prostatectomy.
PrimeArc III delivers calibrated micro-acoustic waves for at-home vascular maintenance, while Clinical LiSWT utilizes high-energy acoustic pressure shockwaves delivered by medical equipment.
Targeted, low-intensity acoustic energy delivered through PrimeArc's dual external contact zones for safe home use.
Defined acoustic-energy pulses delivered through dedicated medical equipment and clinical protocols.
WHY THIS RESEARCH MATTERS
Clinical LiSWT has been studied in erectile-health research using dedicated acoustic-wave equipment and defined protocols.
EAU guideline ↗ 2026 Cochrane review ↗ 2026 RCT meta-analysis ↗ University of Utah pricing ↗
PrimeArc III undergoes final assembly and quality verification in the United States before entering OGO’s domestic fulfillment network.
01 / U.S. ASSEMBLY
PrimeArc III’s final assembly is completed in the U.S. as part of OGO’s controlled production flow.
02 / QUALITY VERIFICATION
Each unit goes through final quality verification in the United States before it is released for customer fulfillment.
03 / DOMESTIC FULFILLMENT
Domestic inventory is routed from the closest available U.S. fulfillment location whenever practical.
The dual-ring architecture combines primary device positioning with a secondary support ring designed to help maintain penile firmness by reducing blood outflow during use.
The larger ring establishes the main fit and helps keep PrimeArc oriented during use.
This support ring is designed to help maintain and prolong an erection by reducing blood outflow from the penis.
* Fixed-size, non-adjustable support ring: approx. 34 mm inner diameter / 44 mm outer diameter. The opening is sized with reference to average U.S. erect penile girth data to provide supportive compression during use. Fit may vary by individual anatomy.
The larger ring helps position PrimeArc during use. The smaller support ring is designed to help maintain and prolong an erection by reducing blood outflow from the penis.
Successful erectile rehabilitation is not defined by medication alone; it depends on maintaining neurovascular responsiveness, appropriate sensory input, and the hemodynamic mechanisms required for erection. Devices like PrimeArc III complement clinical low-intensity shockwave therapy with targeted micro-acoustic energy, providing controlled, non-invasive acoustic stimulation to the external perineal and scrotal regions as a drug-free, at-home adjunct. This allows patients to maintain a more consistent rehabilitation routine between clinic-based treatment sessions.
Reported erections felt firmer and more consistent during sexual activity.
Reported reaching an erection more easily, with less time or stimulation required.
Reported better ability to maintain erection firmness throughout sexual activity.
Reported greater overall satisfaction with sexual performance and intimate experiences.
Reported feeling more confident, relaxed, and assured during sexual activity.
Reported more frequent morning or spontaneous erections during the reporting period.
Reported they would continue using PrimeArc III as part of their regular sexual-wellness routine.
* Statistics are updated every 90 days based on follow-up surveys from verified customers who have purchased and used PrimeArc III.
Instead of cycling blindly through hardware states, the OGO App puts pattern and intensity selection on screen.
App V2 update: OGO App is currently transitioning to V2 and is temporarily unavailable on the App Store and Google Play. OGO App V2 releases October 10, 2026.
A quieter chapter after the technology story: material and care details in one expandable view.
Real people. Real results. A healthier, more confident you.
Customer feedback will appear here after moderation.
Complete the 90-day program with at least 50 qualifying days. Each qualifying day requires at least 20 total minutes of app-recorded PrimeArc Control activity, and multiple sessions in the same day can be combined. If you do not experience meaningful benefit, you may request a refund under our 90-day money-back guarantee.*
Get comfortable with positioning, the support ring and app controls while establishing a routine that feels natural.
Turn PrimeArc into a repeatable part of your private at-home schedule and settle into the rhythm that works for you.
Stay consistent and let repeatable mechanical stimulation become part of your broader erectile-health routine.
By Day 90, decide whether PrimeArc III has delivered meaningful benefit for your routine. If not, your 90-day money-back guarantee is there for you.*
PRIMEARC III · PRIVATE AT-HOME SYSTEM
An at-home micro-acoustic wellness system designed for private, repeatable use — built to support your performance and personal wellness.
Discreet exterior packaging designed to protect your privacy.
Dedicated support for your product, app and ownership experience.
PrimeArc III includes a 1-year limited warranty. Add OGO Care to extend eligible coverage to 2 years total.
Technology, use, privacy and the evidence behind PrimeArc III.
PrimeArc III is a wearable male wellness system designed to deliver controlled, targeted stimulation through dual pulse actuators and two external contact zones. Its architecture combines focused stimulation, a dual-ring fit system, and app-based personal control in one private at-home device.
No. Clinical Li-ESWT systems generate acoustic pressure or shock waves using specialized medical equipment following strict clinical protocols. PrimeArc III uses dual pulse actuators to deliver targeted stimulation through direct external contact. While both apply physical energy to tissue, they differ fundamentally in how that energy is generated, transmitted, and applied.
No. PrimeArc III is not designed as a conventional vibrator. It is a purpose-built male wellness system that uses dual pulse actuators to deliver targeted stimulation across two external contact zones. Penile vibratory stimulation has been studied in clinical and rehabilitation contexts for erectile function. PrimeArc III brings this targeted stimulation concept into a private, app-controlled at-home format.
The dual pulse actuators deliver stimulation across two separate external contact regions. This creates a broader coverage pattern than a single source and allows dynamic stimulation profiles to be distributed throughout the device.
The two rings have different roles. Ring 1 helps position and stabilize PrimeArc during use. Ring 2 is a support ring designed to help maintain and prolong an erection by reducing blood outflow from the penis.
Erectile response involves both nervous-system signaling and vascular tissue. Penile vibratory stimulation has been investigated in human research in several areas of male sexual function.
PrimeArc III is not intended to replace clinical diagnosis or specialist treatment for erectile dysfunction. It is designed for adjunctive at-home use alongside clinician-directed care, providing targeted stimulation as part of a broader erectile-health routine while professional treatment decisions remain under the direction of a qualified healthcare provider.
Yes. PrimeArc III is designed for private, repeatable at-home use as an adjunct to clinician-directed care between professional sessions. It provides controlled stimulation at home alongside specialist treatment and can be incorporated into a broader erectile-health routine without replacing established clinical protocols.
PrimeArc can be controlled through the OGO App. The app provides access to multiple stimulation patterns and intensity control so the experience can be adjusted to personal preference.
No traditional Bluetooth pairing process is required. Turn on PrimeArc, enable Bluetooth on your phone and open the OGO App. The app detects compatible PrimeArc devices within range and sends control commands directly to the device.
Follow the care instructions supplied with PrimeArc III. Allow the device to dry completely before storage or charging, avoid harsh solvents or abrasive cleaners, and do not soak or submerge the device.
PrimeArc III includes a 1-year limited warranty that activates automatically on the calendar day after the eligible order is marked successfully delivered (T+1). No manual activation is required. If OGO Care is purchased and linked to the device, eligible coverage is extended to 2 years total from that same coverage start date.
PrimeArc is designed around private ownership and at-home use. OGO does not require conventional Bluetooth pairing between the device and phone. Any account, order and app-data practices are governed by OGO's published Privacy Policy.